{
    "code": "06011741",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=06011741",
    "time": "2022-06-17 07:50:16",
    "許可證字號": "衛署醫器輸字第011741號",
    "註銷狀態": "已註銷",
    "註銷日期": "111\/04\/18",
    "註銷理由": "自請註銷",
    "製造許可登錄編號": "QSD1664",
    "有效日期": "111\/08\/12",
    "發證日期": "94\/08\/08",
    "許可證種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第三等級",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00601174100",
    "中文品名": "亞培”妙芮絲”C型肝炎病毒抗體檢驗試劑(第四代)",
    "英文品名": "Murex Anti-HCV Version 4.0",
    "效能": "酵素免疫分析法定性測試人體血清或血漿中之C型肝炎病毒抗體。",
    "醫器規格": "盒裝",
    "劑型": "",
    "包裝": "",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "醫器主類別一": "B血液學及病理學用裝置",
    "醫器次類別一": "",
    "醫器主類別二": "",
    "醫器次類別二": "",
    "醫器主類別三": "",
    "醫器次類別三": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "",
    "限制項目": "02輸　入",
    "申請商名稱": "0932301100  美商亞培股份有限公司台灣分公司",
    "申請商地址": "台北市中山區民生東路三段49號5樓、6樓及51號6樓",
    "主製造廠": [
        {
            "製造廠名稱": "MZA0005000  DiaSorin South Africa (Pty) Ltd.",
            "製造廠廠址": "22 Kyalami Boulevard, Kyalami Business Park, Kyalami 1684, South Africa",
            "製造廠公司地址": "",
            "製造廠國別": "SOUTH AFRICA",
            "製程": ""
        }
    ],
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "060117410001-98.12.21-仿單-108-07-09.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06011741&Seq=005&Type=9"
        },
        {
            "title": "060117410002-98.12.21-外盒-108-07-09.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06011741&Seq=008&Type=8"
        }
    ]
}